Definitive Healthcare Corp. $DH Position Boosted by Cubist Systematic Strategies LLC

Key Points

• Cubist Systematic Strategies LLC significantly increased its holdings in Definitive Healthcare Corp. by 2,456.4%, acquiring an additional 138,640 shares during the 1st quarter, bringing its total to 144,284 shares.
• Definitive Healthcare has received mixed analyst opinions with an average rating of "Hold" and a consensus price target of $4.73, while Stifel Nicolaus has increased their target from $5.00 to $6.00.
• As of the latest report, Definitive Healthcare's stock is down 3.9%, opening at $3.98 with a market cap of $569.70 million and a 52-week range of $2.15 to $5.68.

Cubist Systematic Strategies LLC grew its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 2,456.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 144,284 shares of the company's stock after acquiring an additional 138,640 shares during the quarter. Cubist Systematic Strategies LLC owned about 0.13% of Definitive Healthcare worth $417,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. ProShare Advisors LLC lifted its holdings in Definitive Healthcare by 49.1% in the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after purchasing an additional 4,943 shares during the period. Hsbc Holdings PLC bought a new position in Definitive Healthcare in the 1st quarter valued at about $52,000. Cerity Partners LLC bought a new position in Definitive Healthcare in the 1st quarter valued at about $56,000. Price T Rowe Associates Inc. MD grew its position in Definitive Healthcare by 20.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock valued at $85,000 after buying an additional 3,496 shares in the last quarter. Finally, Western Wealth Management LLC bought a new position in Definitive Healthcare in the 4th quarter valued at about $90,000. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH traded up $0.04 during trading hours on Tuesday, hitting $4.09. 210,779 shares of the company's stock traded hands, compared to its average volume of 249,531. Definitive Healthcare Corp. has a 52 week low of $2.15 and a 52 week high of $5.68. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. The company's fifty day simple moving average is $3.97 and its two-hundred day simple moving average is $3.41. The company has a market cap of $585.44 million, a price-to-earnings ratio of -1.54 and a beta of 1.65.

Analyst Ratings Changes

A number of brokerages recently issued reports on DH. Stifel Nicolaus increased their target price on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Robert W. Baird set a $4.00 target price on shares of Definitive Healthcare in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $4.73.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.